[HTML][HTML] Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management

PS Rawat, A Jaiswal, A Khurana, JS Bhatti… - Biomedicine & …, 2021 - Elsevier
Doxorubicin (Dox) is a secondary metabolite of the mutated strain of Streptomyces peucetius
var. Caesius and belongs to the anthracyclines family. The anti-cancer activity of Dox is …

A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity

M Singh, MM Kadhim, A Turki Jalil, SK Oudah… - Cancer Cell …, 2023 - Springer
Purpose Although doxorubicin chemotherapy is commonly applied for treating different
malignant tumors, cardiotoxicity induced by this chemotherapeutic agent restricts its clinical …

Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis

M Tan, Y Yin, X Ma, J Zhang, W Pan, M Tan… - Cell Death & …, 2023 - nature.com
The glutathione (GSH) system is considered to be one of the most powerful endogenous
antioxidant systems in the cardiovascular system due to its key contribution to detoxifying …

[HTML][HTML] Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies

Y Octavia, CG Tocchetti, KL Gabrielson… - Journal of molecular and …, 2012 - Elsevier
The utility of anthracycline antineoplastic agents in the clinic is compromised by the risk of
cardiotoxicity. It has been calculated that approximately 10% of patients treated with …

Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin

K Hou, J Shen, J Yan, C Zhai, J Zhang, JA Pan… - …, 2021 - thelancet.com
Background Doxorubicin, an anthracycline chemotherapeutic agent, is widely used in the
treatment of many cancers. However, doxorubicin posts a great risk of adverse …

Resveratrol and cancer: focus on in vivo evidence

LG Carter, JA D'Orazio… - Endocrine-related …, 2014 - erc.bioscientifica.com
Resveratrol is a naturally occurring polyphenol that provides a number of anti-aging health
benefits including improved metabolism, cardioprotection, and cancer prevention. Much of …

[HTML][HTML] Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases

BNM Zordoky, IM Robertson, JRB Dyck - Biochimica et Biophysica Acta …, 2015 - Elsevier
Cardiovascular disease is the leading cause of death worldwide. Despite advancements in
diagnosis and treatment of cardiovascular disease, the incidence of cardiovascular disease …

Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention

A Albini, G Pennesi, F Donatelli… - Journal of the …, 2010 - academic.oup.com
Due to the aging of the populations of developed countries and a common occurrence of risk
factors, it is increasingly probable that a patient may have both cancer and cardiovascular …

Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms

D Sinha, N Sarkar, J Biswas, A Bishayee - Seminars in cancer biology, 2016 - Elsevier
Globally, breast cancer is the most frequently diagnosed cancer among women. The major
unresolved problems with metastatic breast cancer is recurrence after receiving objective …

Cardiomyocyte death in doxorubicin-induced cardiotoxicity

YW Zhang, J Shi, YJ Li, L Wei - Archivum immunologiae et therapiae …, 2009 - Springer
Doxorubicin (DOX) is one of the most widely used and successful antitumor drugs, but its
cumulative and dose-dependent cardiac toxicity has been a major concern of oncologists in …